The COCCOS Study: a Transition Program for Young Persons With Chronic Conditions
Launched by UNIVERSITEIT ANTWERPEN ·
Trial Information
Current as of September 25, 2025
Recruiting
Keywords
ClinConnect Summary
This study, called the COCCOS Study, is looking at a new program designed to help young people with long-term health conditions—specifically type 1 diabetes, asthma, and obesity—as they transition from childhood to adult healthcare services. The program aims to support these teens by improving their health and well-being, making the transition smoother, and understanding how both patients and healthcare providers feel about the program. Researchers also want to see if the program is a good use of resources.
Young people with type 1 diabetes, asthma, or obesity may be eligible to join if they fall within the study’s age range. If you take part, you can expect to be involved in activities that help manage your condition during this important transition period, and you’ll be asked about your health and experiences. The study is currently looking for participants, and it involves multiple healthcare centers, so care will be coordinated with your usual doctors. This is a chance to contribute to a program that might make it easier for others your age to manage their health as they grow into adulthood.
Gender
ALL
Eligibility criteria
About Universiteit Antwerpen
The University of Antwerp is a leading research institution based in Belgium, renowned for its commitment to advancing knowledge and innovation in various scientific fields. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to improve healthcare outcomes and enhance understanding of complex medical conditions. The University of Antwerp's dedicated research teams leverage cutting-edge methodologies and state-of-the-art facilities to conduct rigorous studies, ensuring adherence to the highest ethical standards and regulatory requirements. Through its clinical trial initiatives, the university strives to translate research findings into practical applications that benefit patients and contribute to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported